Ipsen to expand production of drugs at Dublin facility

The Ipsen facility in Dublin which will be upgraded in a €27m investment.
Pharmaceutical firm Ipsen is to invest €27m to upgrade and expand its manufacturing facility in Blanchardstown in Dublin.
The investment will facilitate the increased production of medical treatments for niche cancers and rare diseases.